Oral administration of insulin incorporated into the wall of isobutylc
yanoacrylate nanocapsule to diabetic rats induces a long-lasting norma
lization of their fasting glycaemia. In this study, we examined the bi
ological action of encapsulated insulin on DNA and glycogen syntheses
in Chinese hamster ovary cells transfected with the human insulin rece
ptor gene. In the 10(-11) mol/l - 10(-9) mol/l concentration range, en
capsulated insulin elicited responses comparable to those induced by n
ative insulin: at 10(-9) mol/l, the rates of glycogen and DNA synthesi
s were enhanced by factors 3 and 2.5, respectively. Encapsulated insul
in at 10(-7) mol/l evoked receptor desensitization although it did not
induce receptor down-regulation and did not alter receptor recycling
for up to 6 h. Chloroquine decreased the action of native insulin on g
lycogen synthesis, but did not affect the dose-response characteristic
s of encapsulated insulin. Acid-washing of the cells after 1 h of stim
ulation decreased maximal insulin responsiveness and provoked a dose r
esponse curve for encapsulated insulin similar to that of the native h
ormone. Direct measurement of effective insulin binding activity showe
d that encapsulated insulin (at 10(-8) and 10(-7) mol/l) was withdrawn
from the incubation medium 5-8 times less efficiently than native ins
ulin. These data are in agreement with previous results showing that t
he polymeric wall protects encapsulated insulin from degradation. Pers
istence of intact encapsulated insulin inside and outside the cell may
result in modifying signalling events and thus be responsible for the
observed cellular desensitization.